Global Regenerative Medicine Market Expected to Reach XX Million by 2025

2018-03-12 09:53:17

According to a new report published by Reports Monitor titled, “Regenerative Medicine Market by therapy, by product, and by Application: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the regenerative medicine market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025. North America dominates the regenerative medicine market, in terms of value, and is expected to maintain this trend throughout the forecast period. 

Advancement in effective and developed technology, rising funding and supportive initiatives from government and private organizations to assist in the development of regenerative medicinal products and increased awareness among people are vital factors responsible for the increasing development of this market.

Get a Sample PDF Report @

Increasing demand for regenerative medicine in organ transplantation and increased potential of developing countries facilitates the opportunity to new players to enter the market.
However, highly rigorous regenerative process, unaffordable treatment associated with regenerative medicine might be some of the factors restrains the growth of the market.

• Technological advancement in cell based therapies is accounted for major contributor to the market.
• Gene therapy is anticipated to have increase in adaptation and highest contributor to the growth of the market.
•  In application segment, dermatology is expected to have highest share in revenue due to availability of easy grafting techniques for dermatological wound and diseases.
• North America dominate the regenerative medicine market as prsenec of major p,ayers in that region and adaptation of technology by population.

The major companies profiled in the report include Baxter International, Inc, DePuy Synthes, Inc., Acelity Holdings, Stryker Corporation, Medtronic, Inc., capricor therapeutics, Integra LifeSciences Corporation, Organogenesis, NuVasive and Zimmer Biomet Holdings.

About Us:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Mr. Kevin Thomas


+1 513 549 5911 (US)

+44 203 318 2846 (UK)
Email: [email protected]

Related Press Releases